Abivax SA (ABVX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec22

Abivax Soars on Reports of Potential Eli Lilly Acquisition

09:02

Dec17

Abivax SA Announces Positive Phase III Data for Obefazimod in Ulcerative Colitis

21:05

Dec16

Abivax SA reports Q1-Q3 2025 net loss of 254.1 million euros

06:08

Abivax SA released FY2025 Q3 earnings on December 15 After-Market EST, actual revenue USD 749.38 K (forecast USD 1.361 M), actual EPS USD -2.4655 (forecast USD -0.7733)

00:00

Abivax SA released FY2025 9 Months Earnings on December 15 After-Market EST, Actual Revenue USD 4.671 M, Actual EPS USD -4.2533

00:00

Dec15

Abivax SA Reports 49% Drop in Nine-Month Revenue and Completes IPO

21:08

Schedules & Filings

Schedules

Filings

Dec15

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 749.38 K, Net Income -179.85 M, EPS -2.4655

Sep8

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.226 M, Net Income -56.67 M, EPS -0.8932

Jun2

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.05 M, Net Income -56.69 M, EPS -0.8944

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change